none Team
Photo of Sebastian A., none
Sebastian A.
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Vancouver (BC)
Photo of David Belkin, none
David Belkin
Sweet spot: $5.0M
Range: $1 - $100.0M
Photo of Thomas Cuvelier, none
Thomas Cuvelier
Sweet spot: $1M
Range: $100K - $10.0M
Investors in United States, Investors in France, Investors in Norway, Investors in Denmark, Investors in Sweden, Investors in Finland, Investors in United Kingdom
Photo of Yolanda Guo, none
Yolanda Guo
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Los Angeles (CA)
Investors in MarketingTech (Seed), Investors in Education (Series A), Investors in MarketingTech (Series A), Investors in Web3/Blockchain (Seed), Investors in Web3/Blockchain (Series A), Investors in Education (Seed), Investors in Web3/Crypto (Series A), Investors in Web3/Blockchain (Seed), Investors in Web3/Crypto (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Education (Seed), Investors in Web3/Crypto (Seed), Investors in FinTech (Seed), Investors in MarketingTech (Seed), Investors in Web3/Blockchain (Series A), Investors in Web3/Crypto (Series A), Investors in Education (Series A), Investors in FinTech (Series A), Investors in MarketingTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Arthur Polk, none
Arthur Polk
Sweet spot: $10.0M
Range: $1M - $20.0M
Investors in Boston (MA), Investors in San Diego (CA), Investors in New York (NY), Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Drug Delivery (Series A), Investors in Drug Delivery (Pre-seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Series A), Investors in AI (Seed), Investors in AI (Pre-seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series B), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in AI (Series B), Investors in Diagnostics (Seed), Investors in AI (Pre-seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in Drug Delivery (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Pre-seed), Investors in AI (Seed), Investors in Consumer Health (Seed), Investors in AI (Series A), Investors in Digital Health (Seed), Investors in Generative Tech/AI (Pre-seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Seed), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Generative Tech/AI (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in AI (Series A), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Consumer Health (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Diagnostics (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in Health IT (Series A), Investors in BioTech (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in BioTech (Pre-seed), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in AI (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Series B), Investors in Diagnostics (Seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Pre-seed), Investors in Boston / New England (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Generative Tech/AI (Series B), Investors in Drug Delivery (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Seed), Investors in Diverse Investors (Other Lists), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Series A), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Diagnostics (Seed), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Series B), Investors in AI (Series B), Investors in AI (Series A), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Consumer Health (Series A)
Photo of Lukas Rode, none
Lukas Rode
Sweet spot: $1.5M
Range: $1M - $5.0M
Investors in Asia, Investors in Canada, Investors in Europe
Investors in Material Science (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Robotics (Seed), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Robotics (Series B), Investors in Material Science (Series B), Investors in Robotics (Series A), Investors in Material Science (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in Space (Series B), Investors in Space (Series A), Investors in Chemicals (Series B), Investors in Space (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in Robotics (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in Chemicals (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Robotics (Series A), Investors in Chemicals (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series B), Investors in Robotics (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Chemicals (Series B), Investors in Canada (Other Lists)
Photo of Richard Trimble, none
Richard Trimble
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Palo Alto (CA)
Photo of Amalia Bryl, none
Amalia Bryl
Sweet spot: $0
Range: $0 - $0